Our findings in this study suggest liver involvement in 55.6% of these cases emphasising the role of rare heterozygous ABCB4/11 variants as potential markers for identifying those at elevated risk of cholestatic liver disease. Here, ABCB4 is linked to Cholestatic liver disease.